We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
Cap. Flow
-$46M
Cap. Flow %
-9.03%
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$3.68M
2
RRGB icon
Red Robin
RRGB
+$3.46M
3
INTA icon
Intapp
INTA
+$3.34M
4
OI icon
O-I Glass
OI
+$3.16M
5
PDFS icon
PDF Solutions
PDFS
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 25%
2 Technology 21.39%
3 Industrials 20.38%
4 Consumer Discretionary 11.68%
5 Energy 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWSC
376
DELISTED
PowerSchool Holdings, Inc.
PWSC
-62,950
Closed -$1.45M
SILK
377
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-48,555
Closed -$2.57M
MCBC
378
DELISTED
Macatawa Bank Corp
MCBC
-135,792
Closed -$1.5M
MODN
379
DELISTED
MODEL N, INC.
MODN
-72,764
Closed -$2.95M
KRTX
380
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-4,723
Closed -$928K
NETI
381
DELISTED
Eneti Inc.
NETI
-220,384
Closed -$2.21M
AVTA
382
DELISTED
Avantax, Inc. Common Stock
AVTA
-55,494
Closed -$1.42M
TWNK
383
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-69,116
Closed -$1.55M
DICE
384
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-53,408
Closed -$1.67M
BLU
385
DELISTED
BELLUS Health Inc.
BLU
-20,039
Closed -$164K
PRVB
386
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-276,250
Closed -$2.92M
LUNA
387
DELISTED
Luna Innovations Incorporated
LUNA
-210,068
Closed -$1.85M
INBX
388
DELISTED
Inhibrx, Inc. Common Stock
INBX
-30,240
Closed -$745K

Similar funds

EAM Investors's Q1 2023 Portfolio in Review

As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.

  • EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
  • EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
  • EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
  • EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
  • EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
  • EAM Investors opened 139 new positions and closed 144 in Q1 2023.
  • EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.

Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.